Orthofix Medical Inc. Common Stock (DE) (OFIX) Stock Price

OFIXStock

$9.70−34.19%52W

Market Cap$392.09M

P/E—

PEG Ratio48.83

Div yield—

Beta0.64

OFIX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-35.85%

Price vs S&P 500 (4W)-22.42%

PEG Ratio48.83

VGM Score53.08

P/CF (Annual)12.45x

Book Value / Share (Quarterly)$10.78

P/TBV (Annual)1.59x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)21.30%

Cash Flow / Share (Quarterly)$-0.11

Price vs S&P 500 (YTD)-48.84%

Gross Margin (TTM)70.75%

Net Profit Margin (TTM)-7.27%

EPS (TTM)$-1.50

10-Day Avg Trading Volume0.25M

EPS Excl Extra (TTM)$-1.50

Revenue Growth (5Y)15.13%

EPS (Annual)$-2.33

ROI (Annual)-14.74%

Gross Margin (Annual)68.83%

Net Profit Margin (5Y Avg)-11.96%

Cash / Share (Quarterly)$2.98

Revenue Growth QoQ (YoY)1.58%

ROA (Last FY)-10.84%

Revenue Growth TTM (YoY)2.59%

EBITD / Share (TTM)$-0.85

ROE (5Y Avg)-17.61%

Operating Margin (TTM)-5.69%

Cash Flow / Share (Annual)$-0.03

P/B Ratio0.95x

P/B Ratio (Quarterly)1.06x

Net Income / Employee (Annual)$-57,400

EV / Revenue (TTM)0.64x

Net Interest Coverage (TTM)-4.19x

ROA (TTM)-7.04%

EV / EBITDA (TTM)278.51x

EPS Incl Extra (Annual)$-2.33

Current Ratio (Annual)2.45x

Quick Ratio (Quarterly)1.61x

3-Month Avg Trading Volume0.40M

52-Week Price Return-34.19%

Revenue / Employee (TTM)$514,300

Tangible BV / Share (Quarterly)$9.06

P/S Ratio (Annual)0.50x

Asset Turnover (Annual)0.97x

52-Week High$16.99

Operating Margin (5Y Avg)-8.76%

EPS Excl Extra (Annual)$-2.33

CapEx CAGR (5Y)7.34%

Tangible BV CAGR (5Y)4.94%

26-Week Price Return-23.92%

Quick Ratio (Annual)1.30x

13-Week Price Return2.21%

Total Debt / Equity (Annual)0.39x

Current Ratio (Quarterly)2.87x

Enterprise Value$529.17M

Revenue / Share Growth (5Y)-0.19%

Asset Turnover (TTM)0.97x

Book Value / Share Growth (5Y)-9.29%

Revenue / Employee (Annual)$512,300

Inventory Turnover (Annual)1.42x

Pretax Margin (Annual)-11.04%

Cash / Share (Annual)$2.06

3-Month Return Std Dev64.41%

Gross Margin (5Y Avg)70.14%

Net Income / Employee (TTM)$-37,400

EBITDA Interim CAGR (5Y)-8.18%

ROE (Last FY)-20.49%

Net Interest Coverage (Annual)-2.19x

EPS Basic Excl Extra (Annual)$-2.33

P/FCF (TTM)17.40x

Receivables Turnover (TTM)6.12x

Total Debt / Equity (Quarterly)0.54x

EPS Incl Extra (TTM)$-1.50

Receivables Turnover (Annual)6.08x

ROI (TTM)-9.43%

P/S Ratio (TTM)0.50x

Pretax Margin (5Y Avg)-10.64%

Revenue / Share (Annual)$20.76

Tangible BV / Share (Annual)$9.47

Price vs S&P 500 (52W)-52.75%

Year-to-Date Return-36.02%

5-Day Price Return-0.92%

EPS Normalized (Annual)$-2.33

ROA (5Y Avg)-10.73%

Net Profit Margin (Annual)-11.21%

Month-to-Date Return-17.80%

Cash Flow / Share (TTM)$-2.76

EBITD / Share (Annual)$-1.34

Operating Margin (Annual)-9.90%

LT Debt / Equity (Annual)0.35x

P/CF (TTM)12.16x

ROI (5Y Avg)-14.15%

LT Debt / Equity (Quarterly)0.51x

EPS Basic Excl Extra (TTM)$-1.50

P/TBV (Quarterly)1.26x

P/B Ratio (Annual)1.33x

Inventory Turnover (TTM)1.37x

Pretax Margin (TTM)-7.21%

Book Value / Share (Annual)$11.30

Price vs S&P 500 (13W)0.26%

Beta0.64x

P/FCF (Annual)8.30x

Revenue / Share (TTM)$20.40

ROE (TTM)-13.44%

52-Week Low$8.85

vGradeB

gGradeC

mGradeC

vgmGradeC

OFIX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.03	$0.07	+334.00%(+$0.10)
Q1 2026	May 5, 2026	-$0.29	-$0.11	+61.03%(+$0.18)
Q4 2025	Feb 24, 2026	$0.41	$0.24	-42.70%(-$0.18)
Q3 2025	Nov 4, 2025	$0.12	$0.20	+64.67%(+$0.08)
Q2 2025	Aug 5, 2025	$0.04	$0.13	+223.50%(+$0.09)

OFIX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.09

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
OFIXOrthofix Medical Inc. Common Stock (DE)	B	C	C	$9.70
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About Orthofix Medical Inc. Common Stock (DE)

Orthofix Medical Inc. is a medical device company specializing in orthopedic and spine solutions. The Global Spine segment, which generates the majority of revenue, provides bone growth therapies, spinal implants, biologics, and enabling technologies for spinal procedures. The Global Limb Reconstruction segment offers solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies.